These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 7696922

  • 1. Growth of primary human acute lymphoblastic and myeloblastic leukemia in SCID mice.
    De Lord C, Clutterbuck R, Powles R, Morilla R, Hanby A, Titley J, Min T, Millar J.
    Leuk Lymphoma; 1994 Dec; 16(1-2):157-65. PubMed ID: 7696922
    [Abstract] [Full Text] [Related]

  • 2. Growth of primary human acute leukemia in severe combined immunodeficient mice.
    De Lord C, Clutterbuck R, Titley J, Ormerod M, Gordon-Smith T, Millar J, Powles R.
    Exp Hematol; 1991 Oct; 19(9):991-3. PubMed ID: 1893976
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G, Shultz LD, Bertolini F.
    Int J Cancer; 2008 Nov 01; 123(9):2222-7. PubMed ID: 18688847
    [Abstract] [Full Text] [Related]

  • 5. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
    Bergstrom D, Leyton JV, Zereshkian A, Chan C, Cai Z, Reilly RM.
    Nucl Med Biol; 2016 Oct 01; 43(10):635-41. PubMed ID: 27497632
    [Abstract] [Full Text] [Related]

  • 6. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP, Shao L, Billman GF, Yu J.
    Stem Cells; 2001 Oct 01; 19(5):443-52. PubMed ID: 11553853
    [Abstract] [Full Text] [Related]

  • 7. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse.
    Lock RB, Liem N, Farnsworth ML, Milross CG, Xue C, Tajbakhsh M, Haber M, Norris MD, Marshall GM, Rice AM.
    Blood; 2002 Jun 01; 99(11):4100-8. PubMed ID: 12010813
    [Abstract] [Full Text] [Related]

  • 8. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
    Kong Y, Liu YR, Liu KY, Huang XJ, Ishikawa F, Harada M.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun 01; 20(3):762-8. PubMed ID: 22739198
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice.
    Terpstra W, Prins A, Visser T, Wognum B, Wagemaker G, Löwenberg B, Wielenga J.
    Leukemia; 1995 Sep 01; 9(9):1573-7. PubMed ID: 7658726
    [Abstract] [Full Text] [Related]

  • 14. Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice.
    Dialynas DP, Lee MJ, Gold DP, Shao Le, Yu AL, Borowitz MJ, Yu J.
    Blood; 2001 May 15; 97(10):3218-25. PubMed ID: 11342452
    [Abstract] [Full Text] [Related]

  • 15. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
    Woiterski J, Ebinger M, Witte KE, Goecke B, Heininger V, Philippek M, Bonin M, Schrauder A, Röttgers S, Herr W, Lang P, Handgretinger R, Hartwig UF, André MC.
    Int J Cancer; 2013 Oct 01; 133(7):1547-56. PubMed ID: 23526331
    [Abstract] [Full Text] [Related]

  • 16. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1997 Oct 01; 209(4):178-85. PubMed ID: 9293448
    [Abstract] [Full Text] [Related]

  • 17. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE.
    Leukemia; 2003 Apr 01; 17(4):760-3. PubMed ID: 12682634
    [Abstract] [Full Text] [Related]

  • 18. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O, Nguyen B, Huso D, Kim KT, Li Y, Witte L, Hicklin DJ, Brown P, Small D.
    Cancer Res; 2006 May 01; 66(9):4843-51. PubMed ID: 16651440
    [Abstract] [Full Text] [Related]

  • 19. Preclinical testing of antileukemic drugs using an in vivo model of systemic disease.
    Lock RB, Liem NL, Papa RA.
    Methods Mol Med; 2005 May 01; 111():323-34. PubMed ID: 15911988
    [Abstract] [Full Text] [Related]

  • 20. Childhood acute myeloid leukemia in mice with severe combined immunodeficiency.
    Chelstrom LM, Gunther R, Simon J, Raimondi SC, Krance R, Crist WM, Uckun FM.
    Blood; 1994 Jul 01; 84(1):20-6. PubMed ID: 8018918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.